...
首页> 外文期刊>BMC Women s Health >Influence of co-morbidity on body composition changes after weight loss intervention among overweight housewives: a follow-up study of the MyBFF@home
【24h】

Influence of co-morbidity on body composition changes after weight loss intervention among overweight housewives: a follow-up study of the MyBFF@home

机译:合并症对超重家庭主妇减肥干预后机体组成变化的影响:MyBFF @ home的随访研究

获取原文
           

摘要

Obesity is a risk factor for co-morbidities such as diabetes, hypertension, osteoarthritis and cardiovascular diseases. However, it is unclear if the presence of co-morbidities has any effect on the magnitude of body composition changes following weight reduction programmes. Thus, this study aimed to determine changes in body composition among obese housewives with and without co-morbidities after they participated in a weight loss intervention. This is a follow-up study among 84 obese housewives without co-morbidities aged 18 to 59?years old who previously participated as a control group (delayed intervention, G1) in the My Body is Fit and Fabulous at Home (MyBFF@home) Phase II. Baseline data were obtained from 12?month data collection for this group. A new group of 42 obese housewives with co-morbidities (G2) were also recruited. Both groups received a 6?month intervention (July–December 2015) consisting of dietary counselling, physical activity (PA) and self-monitoring tools (PA diary, food diary and pedometer). Study parameters included weight, height, waist circumference, blood pressure and body compositions. Body compositions were measured using a bioelectrical impedance analysis device, Inbody 720. Descriptive and repeated measures ANOVA analyses were performed using SPSS 21. There were reductions in mean body fat, fat mass and visceral fat area, particularly among obese women without co-morbidities. There were also decreases fat and skeletal muscle from baseline to month six with mean difference???0.12 (95% CI: -0.38, 0.14) and visceral fat area from month three to month six with mean difference???9.22 (??17.87, ??0.56) for G1. G2 showed a decreasing pattern of skeletal muscle from baseline to month six with mean difference???0.01(95% CI: -0.38, 0.37). There was a significant difference for group effect of visceral fat area (p?
机译:肥胖是糖尿病,高血压,骨关节炎和心血管疾病等合并症的危险因素。但是,目前尚不清楚合并症的存在是否对减重计划后的身体成分变化有任何影响。因此,本研究旨在确定肥胖家庭主妇参与减肥干预后有无合并症的身体成分变化。这是一项针对84位年龄在18至59岁之间并没有合并症的肥胖家庭主妇的随访研究,这些家庭主妇以前曾作为对照组(延迟干预,G1)参加了“我的身体健康而美好”在家(MyBFF @ home)第二阶段。从该组的12个月数据收集中获得基线数据。还招募了一组新的42名肥胖合并症的家庭主妇。两组均接受了为期6个月的干预(2015年7月至12月),包括饮食咨询,身体活动(PA)和自我监控工具(PA日记,食品日记和计步器)。研究参数包括体重,身高,腰围,血压和身体成分。使用生物电阻抗分析仪Inbody 720测量身体成分。采用SPSS 21进行描述性和重复性分析。通过ANOVA分析,特别是在没有合并症的肥胖女性中,平均体脂,脂肪量和内脏脂肪面积减少。从基线到第六个月,脂肪和骨骼肌也有减少,平均差为0.12(95%CI:-0.38,0.14),从第三个月到第六个月,内脏脂肪面积有平均差为9.22(? G1为17.87,?0.56)。从基线到第六个月,G2显示出骨骼肌的减少模式,平均差为0.01(95%CI:-0.38,0.37)。内脏脂肪面积的群效应有显着差异(p <0.05),平均差异为11.49(95%CI:-20.07,2.91)。结果表明,与身体其他部位相比,干预计划可有效减少内脏脂肪的面积。没有合并症的肥胖参与者表现出更理想的身体组成变化。无论发病情况如何,内脏脂肪面积均减少。因此,与没有合并症的患者相比,合并症患者的体重管理工作并不那么直接,需要彻底和量身定制的策略来获得更大的成功机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号